DSLT for Reducing Medication in Glaucoma

Abroad (travel likely)Recruiting

Conditions

Primary Open Angle Glaucoma · Ocular Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Eye Institute of West Florida, Largo, Florida, United States
Contact: Study coordinator (Renee Bondurant) · Renee.Bondurant@eyespecialist.com · 727-450-4668
Contact: Principal Investigator (Neel Desai, MD)

Study leads

Neel Desai, MD
Principal Investigator
The Eye Institute of West Florida

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study

Primary Open Angle Glaucoma (POAG) · Ocular Hypertension (OH)

Abroad (travel likely)RecruitingPHASE3

Beverly Hills, United States · Inglewood, United States

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma (POAG) · Ocular Hypertension

Abroad (travel likely)RecruitingPHASE3

Seoul, South Korea

A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital

Primary Open Angle Glaucoma or Ocular Hypertension

Abroad (travel likely)Recruiting

Ikeja, Nigeria

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

Primary Open Angle Glaucoma · Glaucoma · Primary Open Angle Glaucoma or Ocular Hypertension

Abroad (travel likely)Recruiting

Plymouth Meeting, United States